iRadimed (IRMD)
(Delayed Data from NSDQ)
$51.99 USD
-2.07 (-3.83%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $51.89 -0.10 (-0.19%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 2/13/25 |
---|---|
Current Quarter | 0.45 |
EPS Last Quarter | 0.43 |
Last EPS Surprise | 10.26% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 1.67 |
Next Year | 1.72 |
EPS (TTM) | 1.60 |
P/E (F1) | 32.37 |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 19.09M | 19.46M | 72.94M | 80.81M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 19.09M | 19.46M | 72.94M | 80.81M |
Low Estimate | 19.09M | 19.46M | 72.94M | 80.81M |
Year ago Sales | 17.45M | 17.60M | 65.56M | 72.94M |
Year over Year Growth Est. | 9.40% | 10.57% | 11.25% | 10.79% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.45 | 0.42 | 1.67 | 1.72 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | 0.45 | NA | 1.67 | 1.72 |
High Estimate | 0.45 | 0.42 | 1.67 | 1.72 |
Low Estimate | 0.45 | 0.42 | 1.67 | 1.72 |
Year ago EPS | 0.39 | 0.36 | 1.48 | 1.67 |
Year over Year Growth Est. | 15.38% | 16.67% | 12.84% | 2.99% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.45 | 0.42 | 1.67 | 1.72 |
7 Days Ago | 0.45 | 0.42 | 1.67 | 1.72 |
30 Days Ago | 0.43 | 0.42 | 1.61 | 1.71 |
60 Days Ago | 0.43 | 0.42 | 1.61 | 1.71 |
90 Days Ago | 0.43 | 0.42 | 1.61 | 1.71 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.45 | 0.42 | 1.67 | 1.72 |
Zacks Consensus Estimate | 0.45 | 0.42 | 1.67 | 1.72 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.43 | 0.42 | 0.36 | 0.39 | NA |
Estimate | 0.39 | 0.36 | 0.34 | NA | NA |
Difference | 0.04 | 0.06 | 0.02 | NA | 0.04 |
Surprise | 10.26% | 16.67% | 5.88% | NA | 10.94% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more